Review



anti human ulbp1 apc  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems anti human ulbp1 apc
    Anti Human Ulbp1 Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human ulbp1 apc/product/R&D Systems
    Average 93 stars, based on 12 article reviews
    anti human ulbp1 apc - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    human ulbp-1 apc-conjugated antibody  (Bio-Techne corporation)
    94
    Bio-Techne corporation human ulbp-1 apc-conjugated antibody
    Human Ulbp 1 Apc Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ulbp-1 apc-conjugated antibody/product/Bio-Techne corporation
    Average 94 stars, based on 1 article reviews
    human ulbp-1 apc-conjugated antibody - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti human ulbp1 apc  (R&D Systems)
    93
    R&D Systems anti human ulbp1 apc
    Anti Human Ulbp1 Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human ulbp1 apc/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    anti human ulbp1 apc - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    ulbp1  (R&D Systems)
    94
    R&D Systems ulbp1
    Ulbp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ulbp1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    ulbp1 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    murine anti human ulbp1 apc  (R&D Systems)
    93
    R&D Systems murine anti human ulbp1 apc
    Murine Anti Human Ulbp1 Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine anti human ulbp1 apc/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    murine anti human ulbp1 apc - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    apc anti human ulbp1  (R&D Systems)
    93
    R&D Systems apc anti human ulbp1
    Apc Anti Human Ulbp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apc anti human ulbp1/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    apc anti human ulbp1 - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    ulbp1 apc  (R&D Systems)
    94
    R&D Systems ulbp1 apc
    Ulbp1 Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ulbp1 apc/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    ulbp1 apc - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    ulbp1 pe  (R&D Systems)
    93
    R&D Systems ulbp1 pe
    (A) MICA, MICB, <t>ULBP1,</t> ULBP2, DR4, DR5 and HLA expression was assessed on NALM-6 treated with vehicle control (upper) and with Bortezomib (lower) by flow cytometry. Live cells were gated for analysis based on forward and side scatter parameters. Histograms show fluorescence of unstained cells (grey line) compared with fluorescence of cells stained with specific antibody (black line). Representative data from one of 3 experiments is shown. (B) ΔMFI (mean fluorescence intensity in stained minus mean fluorescence intensity in unstained) showing mean +/- SD from 3 independent experiments with i) Bortezomib ii) Valporate and iii) Troglitazone treated NALM-6. (*p<0.05, **p<0.01 when comparing expression of each ligand in vehicle and drug-treated cells).
    Ulbp1 Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ulbp1 pe/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    ulbp1 pe - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) MICA, MICB, ULBP1, ULBP2, DR4, DR5 and HLA expression was assessed on NALM-6 treated with vehicle control (upper) and with Bortezomib (lower) by flow cytometry. Live cells were gated for analysis based on forward and side scatter parameters. Histograms show fluorescence of unstained cells (grey line) compared with fluorescence of cells stained with specific antibody (black line). Representative data from one of 3 experiments is shown. (B) ΔMFI (mean fluorescence intensity in stained minus mean fluorescence intensity in unstained) showing mean +/- SD from 3 independent experiments with i) Bortezomib ii) Valporate and iii) Troglitazone treated NALM-6. (*p<0.05, **p<0.01 when comparing expression of each ligand in vehicle and drug-treated cells).

    Journal: Leukemia & lymphoma

    Article Title: Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands

    doi: 10.3109/10428194.2012.708026

    Figure Lengend Snippet: (A) MICA, MICB, ULBP1, ULBP2, DR4, DR5 and HLA expression was assessed on NALM-6 treated with vehicle control (upper) and with Bortezomib (lower) by flow cytometry. Live cells were gated for analysis based on forward and side scatter parameters. Histograms show fluorescence of unstained cells (grey line) compared with fluorescence of cells stained with specific antibody (black line). Representative data from one of 3 experiments is shown. (B) ΔMFI (mean fluorescence intensity in stained minus mean fluorescence intensity in unstained) showing mean +/- SD from 3 independent experiments with i) Bortezomib ii) Valporate and iii) Troglitazone treated NALM-6. (*p<0.05, **p<0.01 when comparing expression of each ligand in vehicle and drug-treated cells).

    Article Snippet: The following antibodies were used for analysis of NKG2D ligand, TRAIL ligand and HLA class I expression: MICA-PE (FAB1300P), MICB-APC (FAB1599A), ULBP1-PE (IC1380P), ULBP2-APC (FAB1298A) from R&D Systems; HLA-ABC-FITC (555552), from BD Biosciences; DR4-APC (307208) and DR5-PE (307406) from BioLegend.

    Techniques: Expressing, Flow Cytometry, Fluorescence, Staining

    (A-C) Scatter plots showing effect of drug treatment on NKG2D ligand expression (ΔMFI above isotype control) for each of 3 primary ALL samples treated in duplicate with: A) 50nM Bortezomib, B) 1mM Valproate and C) 5μM Troglitazone compared with vehicle controls. Ligands MICA, MICB, ULBP1 and ULBP2 as indicated (*p<0.05, **p<0.01).

    Journal: Leukemia & lymphoma

    Article Title: Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands

    doi: 10.3109/10428194.2012.708026

    Figure Lengend Snippet: (A-C) Scatter plots showing effect of drug treatment on NKG2D ligand expression (ΔMFI above isotype control) for each of 3 primary ALL samples treated in duplicate with: A) 50nM Bortezomib, B) 1mM Valproate and C) 5μM Troglitazone compared with vehicle controls. Ligands MICA, MICB, ULBP1 and ULBP2 as indicated (*p<0.05, **p<0.01).

    Article Snippet: The following antibodies were used for analysis of NKG2D ligand, TRAIL ligand and HLA class I expression: MICA-PE (FAB1300P), MICB-APC (FAB1599A), ULBP1-PE (IC1380P), ULBP2-APC (FAB1298A) from R&D Systems; HLA-ABC-FITC (555552), from BD Biosciences; DR4-APC (307208) and DR5-PE (307406) from BioLegend.

    Techniques: Expressing